Virax Biolabs Group Ltd Operating Expense
Virax Biolabs Group Ltd (VRAX) reported Operating Expense of $6.11 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2025-07-02
| Period end | Operating Expense 12 month |
|---|---|
| 2025-03-31 | $6.11M 20-F · filed 2025-07-02 |
| 2024-03-31 | $6.55M 20-F · filed 2025-07-02 |
| 2023-03-31 | $5.73M 20-F · filed 2025-07-02 |
| 2022-03-31 | $1.73M 20-F · filed 2024-08-20 |
| 2021-03-31 | $635.10K 20-F · filed 2022-08-12 |